ReviewCancers2021

Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma.

Gary Tincknell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.